Exploring locoregional treatment reporting in neoadjuvant systemic breast cancer treatment studies: A systematic review

- Jiang, Michael, Avery, Kerry, MacKenzie, Mairead, Meyn, Anne, Poulakaki, Fiorita, Richardson, Andrea L., Sepulveda, Karla, Spillane, Andrew, Thompson, Alastair M., Werutsky, Gustavo, Wright, Jean L., Zdenkowski, Nicholas, Ahmed, Rosina, Cowan, Katherine, McIntosh, SA, Potter, S, de Boniface, Jana, Chatterjee, Sanjoy, Dodwell, David, Dubsky, Peter, Finestone, Sandy, Iwata, Hiroji, Lee, Han-Byoel

Efficacy and safety of neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy regimen in Chinese patients with HER2-positive early breast cancer: a real-world retrospective multi-center cohort study

- Zhou, Meirong, Wang, Shouman, Wang, Jianguo, Cao, Hong, Xu, Haifan, Dai, Bin, Tang, Peizhi, Qian, Liyuan, Zhao, Xi, Xiao, Jun, Zhou, Huaiying, Hu, Jinhui, Wan, Nengbin, Ding, Li, Tripodi, D, Zdenkowski, Nicholas, O'Keefe, TJ, Sanchez, AM, Chen, L, Zhang, P, Xu, F, Yuan, Songlin, Hu, Xiongqiang, Zhou, Wei, Qing, Bohua, Liu, Mingwen, Sun, Weihua, Fan, Peizhi

Patient-reported outcomes with neoadjuvant vs adjuvant systemic therapy for operable breast cancer

- Zdenkowski, Nicholas, Butow, Phyllis, Spillane, Andrew, Douglas, Charles, Snook, Kylie, Jones, Mark, Oldmeadow, Christopher, Fewster, Sheryl, Beckmore, Corinna, Boyle, Frances M.

A decision aid for women considering neoadjuvant systemic therapy for operable invasive breast cancer: development and protocol of a phase II evaluation study (ANZ1301 DOMINO)

- Zdenkowski, Nicholas, Butow, Phyllis, Hutchings, Elizabeth, Douglas, Charles, Coll, Joseph R., Boyle, Frances M.

A survey of Australian and New Zealand clinical practice with neoadjuvant systemic therapy for breast cancer

- Zdenkowski, N., Butow, P., Mann, G. B., Fewster, S., Beckmore, C., Isaacs, R., Douglas, C., Boyle, F. M.

Neoadjuvant chemotherapy: what does it take to tAnGo?

- Zdenkowski, Nicholas, McCarthy, Nicole